Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril/valsartan effects on sST2 and Gal-3 in chronic heart failure
ChiCTR1900026530Phase 4Not yet recruiting
- Sponsor
- Yongchuan Hospital Affiliated to Chongqing Medical University
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of sacubitril + valsartan in chronic heart failure (CHF) (2 arms), sponsored by Yongchuan Hospital Affiliated to Chongqing Medical University. Primary endpoints: sST2 and Gal-3. Planned start Nov 2019; status: not yet recruiting.
02
Drugs
sacubitril + valsartan
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on ChiCTR1900026530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026530.